Prognostic value of cardiac troponin in chronic stable heart failure: A systematic review

Heart

Volumn 98, Issue 24, 2012, Pages 1778-1786

  Nagarajan, Vijaiganesh ^a   Hernandez, Adrian V ^a   Tang, W H Wilson ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T;

CHEMOLUMINESCENCE; DIASTOLIC HEART FAILURE; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC HEART FAILURE;

HEART FAILURE; HUMANS; PROGNOSIS; SURVIVAL RATE; TROPONIN I; TROPONIN T; WORLD HEALTH;

EID: 84870449802     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-301779     Document Type: Review

References (38)

1. Thygesen K, Alpert JS, White HD, et al. Task force for the redefinition of myocardial infarction, Jaffe AS, Apple FS, Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
2. Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 2004;125:1877-84. (Pubitemid 38648423)
3. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. ndependent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-17. (Pubitemid 30451779)
4. Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088-96. (Pubitemid 43113440)
5. Nagarajan V, Tang WH. Biomarkers in advanced heart failure: diagnostic and therapeutic insights. Congest Heart Fail 2011;17:169-74.
6. Peacock WF, De Marco T, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117-26. (Pubitemid 351679598)
7. Kociol RD, Pang PS, Gheorghiade M, et al. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010;56:1071-8.
8. Wencker D, Chandra M, Nguyen K, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003;111:1497-504. (Pubitemid 38063282)
9. Freda BJ, Tang WH, Van Lente F, et al. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002;40:2065-71. (Pubitemid 36005889)
10. Mohammed AA, Januzzi JL Jr. Clinical applications of highly sensitive troponin assays. Cardiol Rev 2010;18:12-19.
11. Morrow DA, Antman EM. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem 2009;55:5-8.
12. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
13. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34. (Pubitemid 28562978)
14. Latini R, Masson S, Anand IS, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9. (Pubitemid 47517535)
15. Wu AH. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression?. Intensive Care Med 2001;27:959-61. (Pubitemid 32662474)
16. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005;142:786-91. (Pubitemid 40593781)
17. Feng J, Schaus BJ, Fallavollita JA, et al. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001;103:2035-7. (Pubitemid 32373003)
18. Narula J, Pandey P, Arbustini E, et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 1999;96:8144-9. (Pubitemid 29328422)
19. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
20. de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
21. Healey JS, Davies RF, Smith SJ, et al. Prognostic use of cardiac troponin T and troponin I in patients with heart failure. Can J Cardiol 2003;19:383-6. (Pubitemid 36603504)
22. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7. (Pubitemid 27255495)
23. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation 2006;113:1424-33. (Pubitemid 43739439)
24. Kawahara C, Tsutamoto T, Sakai H, et al. Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure. Am Heart J 2011;162:639-45.
25. Jungbauer CG, Riedlinger J, Buchner S, et al. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide. Clin Chem Lab Med 2011;49:1899-906.
26. Tentzeris I, Jarai R, Farhan S, et al. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail 2011;13:726-33.
27. Alehagen U, Dahlstrom U, Rehfeld JF, et al. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements. Clin Chem 2010;56:1718-24.
28. Orea-Tejeda A, Sanchez-Gonzalez LR, Castillo-Martinez L, et al. Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients. Cardiol J 2010;17:42-8.
29. Tsutamoto T, Kawahara C, Nishiyama K, et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J 2010;159:63-7.
30. Setsuta K, Seino Y, Kitahara Y, et al. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure. Circ J 2008;72:569-74. (Pubitemid 351679408)
31. Miller WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007;116:249-57. (Pubitemid 47196560)
32. Xue C, Feng Y, Wo J, et al. Prognostic value of high-sensitivity C-reactive protein in patients with chronic heart failure. N Z Med J 2006;119:U2314.
33. Taniguchi R, Sato Y, Nishio Y, et al. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels 2006;21:344-9.
34. Macin SM, Perna ER, Cimbaro, et al. Increased levels of cardiac troponin-T in outpatients with heart failure and preserved systolic function are related to adverse clinical findings and outcome. Coron Artery Dis 2006;17:685-91. (Pubitemid 44934700)
35. Ralli S, Horwich TB, Fonarow GC. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am Heart J 2005;150:1220-7. (Pubitemid 41773526)
36. Stanton EB, Hansen MS, Sole MJ, et al. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure. Can J Cardiol 2005;21:39-43. (Pubitemid 40378517)
37. Hudson MP, O'Connor CM, Gattis WA, et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 2004;147:546-52. (Pubitemid 38880881)
38. Horwich TB, Patel J, MacLellan WR, et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833-8. (Pubitemid 37022125)